Borgia, S. M., Dearden, J., Yoshida, E. M., Shafran, S. D., Brown, A., Ben-Ari, Z., . . . Gane, E. J. (2019). Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.
Citación estilo ChicagoBorgia, Sergio M., et al. Sofosbuvir/velpatasvir for 12 weeks in Hepatitis C Virus-infected Patients With End-stage Renal Disease Undergoing Dialysis. 2019.
Cita MLABorgia, Sergio M., et al. Sofosbuvir/velpatasvir for 12 weeks in Hepatitis C Virus-infected Patients With End-stage Renal Disease Undergoing Dialysis. 2019.
Precaución: Estas citas no son 100% exactas.